David Henderson is a highly successful global biotechnology executive with an extensive background in commercial operations and finance. David focuses on therapeutic areas including rare diseases, oncology, immunology, and specialty biologics. He has experience with all product lifecycle stages, from pipeline to launch, through growth and maturity, to decline associated with generics and branded competition. David is recognized as a results-oriented leader that provides strategic and operational execution in support of business goals. He is extremely passionate about fast growing environments with challenging global objectives. He has demonstrated the ability to both deliver on results and influence at all levels within an organization including c-suite and board of directors all the way to investor relations.